Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2023;34(1):105-7
Article Links
Symptomatic Bilateral Sacroiliitis in a Patient with Juvenile Systemic Lupus Erythematosus: A Rare Association
Vikas Gupta1, Devinderpal Singh Dhanota2
Authors Information

1Department of Rheumatology & Immunology, Dayanand Medical College & Hospital, Ludhiana, Punjab, India
2Department of Radiodiagnosis, Dayanand Medical College & Hospital, Ludhiana, Punjab, India

V Gupta, DS Dhanota

Keywords: juvenile systemic lupus erythematosus, sacroiliitis, juvenile spondyloarthropathy, inflammatory back pain
References
  1. Shbeeb M, Uramoto KM, Gibson LE, O’Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000 May;27(5):1247–50.
  2. Zoma A. Musculoskeletal involvement in systemic lupus erythematosus. Lupus 2004;13(11):851–3.
  3. Grossman JM. Lupus arthritis. Best Pract Res Clin Rheumatol 2009 Aug;23(4):495–506.
  4. Tanatar A, Topal U, GÜl KaradaĞ Ş, SÖnmez HE, Aktay Ayaz N. Coexistence of Juvenile Systemic Lupus Erythematosus and Juvenile Spondyloarthropathy: A Case Report and Review of the Literature. Arch Rheumatol 2020 Mar;35(1):132–6.
  5. Sierra-Jimenez G, Sanchez-Ortiz A, Aceves-Avila FJ, Hernandez-Rios G, Durán-Barragán S, Ramos-Remus C. Tendinous and ligamentous derangements in systemic lupus erythematosus. J Rheumatol 2008 Nov;35(11):2187–91.
  6. Yilmaz N, Yazici A, Özulu TÜrkmen B, Karalok I, Yavuz Ş. Sacroiliitis in Systemic Lupus Erythematosus Revisited. Arch Rheumatol 2020 Jun;35(2):254–8.
  7. Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, et al. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol 2019 Oct;71(10):1599-1613.
  8. Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 2022 Oct 21:ard-2022-223296.
  9. Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 2019 Jun;78(6):736-745.
  10. Zhu LJ, Yang X, Yu XQ. Anti-TNF-alpha therapies in systemic lupus erythematosus. J Biomed Biotechnol 2010;2010:465898.
  11. Costa R, Antunes P, Salvador P, Oliveira P, Marinho A. Secukinumab on Refractory Lupus Nephritis. Cureus 2021 Aug 15;13(8):e17198.
  12. Kaler J, Kaeley GS. Secukinumab-Induced Lupus Erythematosus: A Case Report and Literature Review. J Clin Rheumatol 2021 Dec 1;27(8S):S753-S754.
  13. Koller-Smith L, Oakley S. Secukinumab-induced systemic lupus erythematosus occurring in a patient with ankylosing spondylitis. Rheumatology 2022;61(6): e146–e147.
  14. You H, Zhang G, Wang Q, Zhang S, Zhao J, Tian X, et al. Successful treatment of arthritis and rash with tofacitinib in systemic lupus erythematosus: the experience from a single centre. Ann Rheum Dis 2019 Oct;78(10):1441-1443.
  15. Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA, et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 2018 Jul 21;392(10143):222-231.
  16. Richter P, Cardoneanu A, Burlui AM, Macovei LA, Bratoiu I, Buliga-Finis ON, Rezus E. Why Do We Need JAK Inhibitors in Systemic Lupus Erythematosus? Int J Mol Sci 2022 Oct 4;23(19):11788.